Health
Employees at the Azrieli Center in Tel Aviv go to the stairs to take shelter.

Getting the best sperm on target, naturally

By mimicking the processes in nature that contribute to sperm selection, an Israeli professor is hoping to improve both the success of IVF and the health of infants.   Today doctors choose which sperm to use to fertilize the egg. …

Israeli biomed thrives [video]

Israeli biomed thrives [video]

New products from Israeli companies specializing in biotech, pharma, and medical devices were showcased at ILSI Biomed 2010, this year’s Israeli Life Science’s Conference.   Extensive cooperation between academia and business, an entrepreneurial spirit and a highly-skilled workforce have all …

Direct coping with stress reduces MS attacks

Multiple sclerosis patients who actively confront their problems in times of extreme stress are less likely to suffer attacks, according to an Israeli study. Photo by Nati Shohat/Flash 90. The study found that patients with MS who took practical measures …

A birth control pill for men

By jamming the biochemical machinery of sperm, an Israeli professor has created a new pill that could finally place the responsibility of birth control with men.   Biochemist Prof. Haim Breitbart hopes a new birth control pill for men could …

Stopping schizophrenia before it starts

If administered in the early-onset stages of the disorder, drugs used to treat schizophrenia may have the power to prevent it, according to Israeli researchers.   Photo by Flash90. New Israeli research suggests that schitzophrenia could be prevented if caught …

Pre-empting multiple sclerosis

A breakthrough finding from Israel may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease multiple sclerosis.

A drug discovery boutique

There’s new hope in the fight against diseases ranging from arthritis to liver cancer and glaucoma from Israel’s biotech drug developer Can-Fite.   Building a platform for treatment: Prof. Pnina Fishman, CEO of Can-Fite. It may take four more years …